Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 18.32%1.53B | 10.48%391.11M | 18.37%378.73M | 22.50%394.09M | 23.00%369.98M | 38.65%1.3B | 34.52%354M | 33.71%319.95M | 43.79%321.7M | 44.00%300.78M |
Operating revenue | 18.32%1.53B | 10.48%391.11M | 18.37%378.73M | 22.50%394.09M | 23.00%369.98M | 38.65%1.3B | 34.52%354M | 33.71%319.95M | 43.79%321.7M | 44.00%300.78M |
Cost of revenue | -7.03%545.62M | 14.85%142.57M | 13.84%136.61M | 16.18%138.32M | -42.72%128.13M | 66.09%586.89M | 29.31%124.13M | 30.63%120M | 38.93%119.05M | 180.30%223.71M |
Gross profit | 39.29%988.29M | 8.12%248.55M | 21.09%242.13M | 26.22%255.77M | 213.78%241.85M | 21.98%709.54M | 37.51%229.87M | 35.62%199.95M | 46.81%202.65M | -40.28%77.08M |
Operating expense | 56.49%539.73M | 48.12%136.83M | 23.74%108.38M | 94.94%153.05M | 63.69%141.47M | -36.77%344.9M | -72.74%92.38M | 41.98%87.59M | 4.92%78.51M | 23.20%86.42M |
Selling and administrative expenses | 39.09%371.63M | 34.34%101.51M | 15.17%84.24M | 47.66%92.44M | 67.19%93.44M | 14.27%267.19M | 13.41%75.56M | 48.74%73.14M | 4.19%62.61M | -3.54%55.89M |
-Selling and marketing expense | 25.54%177.94M | 23.75%43.64M | 16.90%43.72M | 23.53%45.04M | 39.64%45.55M | 41.39%141.74M | 30.69%35.26M | 47.16%37.4M | 32.61%36.46M | 60.25%32.62M |
-General and administrative expense | 54.39%193.69M | 43.61%57.87M | 13.36%40.52M | 81.29%47.41M | 105.81%47.9M | -6.08%125.46M | 1.65%40.3M | 50.43%35.74M | -19.78%26.15M | -38.09%23.27M |
Research and development costs | 116.32%168.1M | 109.97%35.33M | 67.11%24.15M | 281.11%60.6M | 57.29%48.02M | -75.07%77.71M | -93.82%16.82M | 15.44%14.45M | 7.91%15.9M | 150.20%30.53M |
Operating profit | 23.01%448.56M | -18.75%111.71M | 19.03%133.74M | -17.25%102.73M | 1,174.28%100.38M | 907.44%364.64M | 180.08%137.49M | 31.04%112.36M | 96.41%124.14M | -115.86%-9.34M |
Net non-operating interest income expense | 4,606.30%17.17M | 80.30%4.52M | 1,052.92%4.9M | 548.34%4.06M | 351.29%3.69M | 91.67%-381K | 583.04%2.51M | 54.19%-514K | 36.64%-906K | 2.20%-1.47M |
Non-operating interest income | 87.59%36.84M | 26.72%9.57M | 115.88%9.8M | 121.60%8.92M | 142.63%8.55M | 651.55%19.64M | 266.05%7.55M | 800.79%4.54M | 10,225.64%4.03M | 43,937.50%3.52M |
Non-operating interest expense | -1.75%19.67M | 0.08%5.05M | -2.99%4.9M | -1.44%4.86M | -2.64%4.86M | 178.62%20.02M | 95.31%5.04M | 210.82%5.05M | 235.81%4.93M | 230.75%4.99M |
Other net income (expense) | -174.45%-34.76M | -7,259.37%-117.01M | -22.10%37.48M | -5,026.81%-22.42M | 23,113.01%67.2M | 1,051.92%46.68M | 60.71%-1.59M | 3,097.45%48.11M | 67.90%455K | -161.22%-292K |
Gain on sale of security | -210,838.10%-44.3M | -1,196,070.00%-119.6M | 415,333.33%37.37M | -10,364.29%-22.99M | 24,864.63%60.92M | 91.80%-21K | 114.93%10K | 93.79%-9K | 279.20%224K | -403.70%-246K |
Special income (charges) | -81.81%8.52M | 241.78%2.27M | --0 | --0 | 6,414.58%6.25M | 1,107.87%46.85M | 59.82%-1.6M | 3,395.68%48.12M | -41.41%232K | -75.76%96K |
-Less:Other special charges | -102.14%-106K | ---- | ---- | ---- | ---- | 6.35%4.94M | -59.82%1.6M | 151.51%3.67M | 41.41%-232K | 75.76%-96K |
-Gain on sale of property,plant,equipment | -83.75%8.42M | --2.16M | --0 | --0 | --6.25M | --51.79M | --0 | --51.79M | --0 | --0 |
Other non- operating income (expenses) | 813.29%1.02M | 31,700.00%316K | 10,500.00%106K | 57,600.00%575K | 116.20%23K | ---143K | ---1K | --1K | ---1K | ---142K |
Income before tax | 4.88%430.98M | -100.57%-783K | 10.10%176.12M | -31.78%84.37M | 1,642.40%171.27M | 1,438.02%410.94M | 178.53%138.4M | 92.68%159.96M | 99.35%123.69M | -119.18%-11.1M |
Income tax | 40.64%118.54M | -68.57%11.01M | 60.81%45.03M | -24.55%22.3M | 584.54%40.2M | 6,352.37%84.28M | 161.38%35.02M | 28.53%28M | 55.67%29.56M | -155.54%-8.3M |
Net income | -4.35%312.44M | -111.40%-11.79M | -0.65%131.09M | -34.06%62.07M | 4,769.26%131.07M | 1,063.86%326.66M | 186.74%103.38M | 115.50%131.96M | 118.61%94.13M | -106.53%-2.81M |
Net income continuous Operations | -4.35%312.44M | -111.40%-11.79M | -0.65%131.09M | -34.06%62.07M | 4,769.26%131.07M | 1,063.86%326.66M | 186.74%103.38M | 115.50%131.96M | 118.61%94.13M | -106.53%-2.81M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -4.35%312.44M | -111.40%-11.79M | -0.65%131.09M | -34.06%62.07M | 4,769.26%131.07M | 1,063.86%326.66M | 186.74%103.38M | 115.50%131.96M | 118.61%94.13M | -106.53%-2.81M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -4.35%312.44M | -111.40%-11.79M | -0.65%131.09M | -34.06%62.07M | 4,769.26%131.07M | 1,063.86%326.66M | 186.74%103.38M | 115.50%131.96M | 118.61%94.13M | -106.53%-2.81M |
Basic earnings per share | -5.64%4.52 | -111.18%-0.17 | -2.07%1.89 | -35.51%0.89 | 4,875.00%1.91 | 1,068.29%4.79 | 187.36%1.52 | 116.85%1.93 | 119.05%1.38 | -106.35%-0.04 |
Diluted earnings per share | -6.24%4.36 | -111.56%-0.17 | -4.79%1.79 | -33.83%0.88 | 4,775.00%1.87 | 1,062.50%4.65 | 184.48%1.47 | 118.60%1.88 | 118.03%1.33 | -106.56%-0.04 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |